BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16000163)

  • 1. Differential effects of l-DOPA on monoamine metabolism, cell survival and glutathione production in midbrain neuronal-enriched cultures from parkin knockout and wild-type mice.
    Casarejos MJ; Solano RM; Menéndez J; Rodríguez-Navarro JA; Correa C; García de Yébenes J; Mena MA
    J Neurochem; 2005 Aug; 94(4):1005-14. PubMed ID: 16000163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkin deficiency increases the resistance of midbrain neurons and glia to mild proteasome inhibition: the role of autophagy and glutathione homeostasis.
    Casarejos MJ; Solano RM; Rodriguez-Navarro JA; Gómez A; Perucho J; Castaño JG; García de Yébenes J; Mena MA
    J Neurochem; 2009 Sep; 110(5):1523-37. PubMed ID: 19549073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline.
    Casarejos MJ; Menéndez J; Solano RM; Rodríguez-Navarro JA; García de Yébenes J; Mena MA
    J Neurochem; 2006 May; 97(4):934-46. PubMed ID: 16573651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midbrain neuronal cultures from parkin mutant mice are resistant to nitric oxide-induced toxicity.
    Solano RM; Menéndez J; Casarejos MJ; Rodríguez-Navarro JA; García de Yébenes J; Mena MA
    Neuropharmacology; 2006 Aug; 51(2):327-40. PubMed ID: 16701721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial dysfunction in parkin null mice: effects of aging.
    Solano RM; Casarejos MJ; Menéndez-Cuervo J; Rodriguez-Navarro JA; García de Yébenes J; Mena MA
    J Neurosci; 2008 Jan; 28(3):598-611. PubMed ID: 18199761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkin null cortical neuronal/glial cultures are resistant to amyloid-β1-42 toxicity: a role for autophagy?
    Solano RM; Casarejos MJ; Gómez A; Perucho J; de Yébenes JG; Mena MA
    J Alzheimers Dis; 2012; 32(1):57-76. PubMed ID: 22785397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NP7 protects from cell death induced by oxidative stress in neuronal and glial midbrain cultures from parkin null mice.
    Mena MA; Casarejos MJ; Solano R; Rodríguez-Navarro JA; Gómez A; Rodal I; Medina M; de Yebenes JG
    FEBS Lett; 2009 Jan; 583(1):168-74. PubMed ID: 19084014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences and estrogen effects in parkin null mice.
    Rodríguez-Navarro JA; Solano RM; Casarejos MJ; Gomez A; Perucho J; de Yébenes JG; Mena MA
    J Neurochem; 2008 Sep; 106(5):2143-57. PubMed ID: 18643794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic and protective effects of L-dopa on mesencephalic cell cultures.
    Mytilineou C; Han SK; Cohen G
    J Neurochem; 1993 Oct; 61(4):1470-8. PubMed ID: 8376999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cinnarizine, a calcium antagonist that produces human parkinsonism, in parkin knock out mice.
    Serrano A; Menéndez J; Casarejos MJ; Solano RM; Gallego E; Sánchez M; Mena MA; García de Yebenes J
    Neuropharmacology; 2005 Aug; 49(2):208-19. PubMed ID: 15993444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells.
    Rodríguez-Martín E; Canals S; Casarejos MJ; de Bernardo S; Handler A; Mena MA
    J Neurochem; 2001 Aug; 78(3):535-45. PubMed ID: 11483656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic effects of L-DOPA in postnatal midbrain dopamine neuron/cortical astrocyte cocultures.
    Mena MA; Davila V; Sulzer D
    J Neurochem; 1997 Oct; 69(4):1398-408. PubMed ID: 9326268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures.
    Canals S; Casarejos MJ; Rodríguez-Martín E; de Bernardo S; Mena MA
    J Neurochem; 2001 Jan; 76(1):56-68. PubMed ID: 11145978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture.
    Mena MA; Khan U; Togasaki DM; Sulzer D; Epstein CJ; Przedborski S
    J Neurochem; 1997 Jul; 69(1):21-33. PubMed ID: 9202290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture.
    Yamamoto H; Kamegaya E; Hagino Y; Imai K; Fujikawa A; Tamura K; Enokiya T; Yamamoto T; Takeshima T; Koga H; Uhl GR; Ikeda K; Sora I
    Neurochem Int; 2007; 51(2-4):237-44. PubMed ID: 17664021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline of striatal dopamine release in parkin-deficient mice shown by ex vivo autoradiography.
    Sato S; Chiba T; Nishiyama S; Kakiuchi T; Tsukada H; Hatano T; Fukuda T; Yasoshima Y; Kai N; Kobayashi K; Mizuno Y; Tanaka K; Hattori N
    J Neurosci Res; 2006 Nov; 84(6):1350-7. PubMed ID: 16941649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glia-conditioned medium induces de novo synthesis of tyrosine hydroxylase and increases dopamine cell survival by differential signaling pathways.
    de Bernardo S; Canals S; Casarejos MJ; Rodriguez-Martin E; Mena MA
    J Neurosci Res; 2003 Sep; 73(6):818-30. PubMed ID: 12949908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality, oxidative stress and tau accumulation during ageing in parkin null mice.
    Rodríguez-Navarro JA; Casarejos MJ; Menéndez J; Solano RM; Rodal I; Gómez A; Yébenes JG; Mena MA
    J Neurochem; 2007 Oct; 103(1):98-114. PubMed ID: 17623040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyl-L-methionyl-L-Dopa-methyl ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity.
    Minelli A; Conte C; Prudenzi E; Cacciatore I; Cornacchia C; Taha E; Pinnen F
    Free Radic Biol Med; 2010 Jul; 49(1):31-9. PubMed ID: 20307650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.